Morphine Completed Phase 4 Trials for Dyspnea / Neoplasms, Lung Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00338481Red Morphine Drops for Symptomatic Treatment of Dyspnoea in Lung Cancer